On September 10, Centrus fell 8.29% in regular trading, trading at $166.395/share, with turnover of approximately $85.41 million. The decline was primarily driven by the company's announcement of a $500 million public offering of Class A common shares and warrants, triggering significant shareholder dilution concerns.

According to the announcement, the offering consists of 500,000 Class A common shares, pre-funded warrants to purchase approximately 2,005,513 Class A shares, and common warrants to purchase up to 6,992,382 Class A shares. The combined offering was priced at $199.64 per share and accompanying warrants. The company expects the offering to close by Friday, with net proceeds earmarked for general working capital and corporate purposes. Market analysts noted that such large-scale equity dilution typically exerts short-term pressure on existing shareholders' holdings.

Notably, Centrus had already seen its shares slip in pre-market trading on the same day, falling over 8% before the regular session opened. Analysts remain largely constructive on the stock long term, with the consensus rating at overweight and a mean price target of $275.08 as of mid-June. The company reported Q1 adjusted EPS of $1.05 on revenue of $76.7 million earlier this year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)